StockData
Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc. (LRMR) stock

LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$2.99−0.01 (-0.33%)

Close on Nov 17, 2026Market cap $310.61MP/E –Yield –

Larimar Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Larimar Therapeutics's market cap was $283.60M on Nov 11, 2026, against $302.99M a year earlier. Over the last 5 years it ranged from $31.70M to $535.28M, with a median of $221.54M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$283.60M-13.0%
2025Dec 31, 2025$326.10M+32.1%
2024Dec 31, 2024$246.93M+23.6%
2023Dec 29, 2023$199.77M+11.8%
2022Dec 30, 2022$178.70M-6.5%
2021Dec 31, 2021$191.10M-41.9%
2020Dec 31, 2020$328.78M-34.0%
2019Dec 31, 2019$497.79M-77.3%
2018Dec 31, 2018$2.19B+43.7%
2017Dec 29, 2017$1.52B+46.1%
2016Dec 30, 2016$1.04B-49.3%
2015Dec 31, 2015$2.06B-75.5%
2014Dec 31, 2014$8.40B–

More Larimar Therapeutics figures

See a number that looks wrong?